comparemela.com

Latest Breaking News On - Philippe menu - Page 3 : comparemela.com

SOPHiA GENETICS Provides an Update on its DEEP-Lung-IV Multimodal Clinical Study at ASCO 2022

Study leverages deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to.

New yorkUnited statesBen newtonPrantesh jainRoswell park comprehensive cancer centerResearch useEdison digital health platformGe healthcare oncology solutionsGe healthcareAssistant professorRoswell park comprehensive cancerInnovation symposiumPhilippe menuMedical officerImaging fabric coreImaging fabric annotation template

SOPHiA GENETICS Announces Three Poster Presentations and One Online Publication Accepted at the 2022 American Society of Clinical Oncology Annual (ASCO) Meeting

/PRNewswire/ SOPHiA GENETICS (Nasdaq: SOPH), a leader in data-driven medicine, today announced three abstracts accepted for poster presentation and one for.

United statesResearch useAmerican society of clinical oncologySpanish lung cancer groupGe healthcareClinical oncologyAnnual meetingInnovation symposiumPhilippe menuChief medical officerMeeting proceedingsCancer non small cellResearch use onlySophia genetics

AI Widens Search Spaces and Promises More Hits in Drug Discovery

AI platforms are enhancing discovery efforts across modalities small-molecule drugs, RNA-based therapeutics, and protein-based therapeutics.

Noor shakerMolly gibsonMatt clarkAndreas windemuthAmit deshwarNeil thompsonAlexander sardinaGenerative adversarial networksRecursion pharmaceuticalsCentaur chemistRecursion operating systemGenerative tensorial reinforcementLigand expressLigand designGenerate biomedicinesGenerative biology

SOPHiA GENETICS Announces Launch of DEEP-Lung-IV Multimodal Clinical Study

/PRNewswire/ SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine,.

United statesResearch useNorth americaPhilippe menuChief medical officerData driven medicineResearch use onlyLooking statementsSophia genetics

SOPHiA GENETICS Announces Launch of DEEP-Lung-IV Multimodal Clinical Study

/PRNewswire/ SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine,.

United statesResearch useNorth americaPhilippe menuChief medical officerData driven medicineResearch use onlySophia genetics

vimarsana © 2020. All Rights Reserved.